The FDA approved subcutaneous daratumumab/VRd in patients with newly diagnosed multiple myeloma who are not eligible for ASCT. Here’s what you should know. The FDA has approved subcutaneous ...
Abstract: The evolution of wireless communications has been significantly influenced by remarkable advancements in multiple access (MA) technologies over the past five decades, shaping the landscape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results